INTRAMEDICS
Timeline
30 events since 2010Board
Filings
Financial
Establishments
Address
201020122014201620182020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Registered office moved from Ghent to Sint-Denijs-WestremNew registered office: Kortrijksesteenweg 1202 B/C, 9051 Sint-Denijs-Westrem · Previous registered office: Coupure 629 bus 001, 9000 Gent · Board meeting of 18-08-20263 points ▸
- Board meeting, 18-08-2026
- Registered-office move, Kortrijksesteenweg 1202 B/C, 9051 Sint-Denijs-Westrem
- Power of attorney, Dieter Vereecke
Annual accounts 2025 filed NBBabbreviated format · 15 days before the deadline
2025
Highest result from 2012 to 2025 net €2.1m ▲62.1% The operating result of €2.5m and the net result of €2.1m are both a record.
Equity above €2m equity €2.1m ▲60.6% After 14 profitable years in a row, equity reaches €2.1m.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0827622212
Annual accounts 2024 filed PDFabbreviated format · 27 days before the deadline
2024
Equity above €1m equity €1.3m ▲59.8% After 13 profitable years in a row, equity reaches €1.3m.
Annual accounts 2023 filed PDFabbreviated format · 1 day before the deadline
2023
Equity above €500,000 equity €825,266 ▲98.2% After 12 profitable years in a row, equity reaches €825,266.
Annual accounts 2022 filed PDFabbreviated format · 4 days before the deadline
2022
Equity above €200,000 equity €416,457 ▲201% After 11 profitable years in a row, equity reaches €416,457.
1 director appointed, 2 resignationsResignations: THIBAU Marc Pierre Antoine (statutory director) and SKINMEDICON (statutory director) · Appointment: MEDIFA (statutory director) · Permanent representative: BOURAKADI Farah · General meeting of 30-11-20229 points ▸
- Director resignation, THIBAU Marc Pierre Antoine (statutory director), mentioned 3 times in the deed
- Director resignation, SKINMEDICON (statutory director), mentioned twice in the deed
- Director appointment, MEDIFA (statutory director), mentioned twice in the deed
- Permanent representative, BOURAKADI Farah
- Power of attorney, Benjamin De Coninck, mentioned 3 times in the deed
- Amendment of the articles, article 9, mentioned twice in the deed
- General meeting, 30-11-2022
- MEDIFA holds all the shares
- Board composition, SKINMEDICON (statutory director)
- The deed holds 5 more points.
Annual accounts 2021 filed PDFabbreviated format · 5 days before the deadline
2021
Equity above €100,000 equity €138,583 ▲308% After 10 profitable years in a row, equity reaches €138,583.
Annual accounts 2021 filed PDFabbreviated format · 4 days late
Permanent representative: BOURAKADI, FarahChanges of role: THIBAU, Marc Pierre Antoine (statutory director) and Skinmedicon (statutory director) · THIBAU, Marc Pierre Antoine holds 96 shares · BOURAKADI, Farah holds 90 shares · General meeting of 22-06-202118 points ▸
- General meeting, 22-06-2021
- THIBAU, Marc Pierre Antoine holds 96 shares
- BOURAKADI, Farah holds 90 shares
- 186 shares, mentioned twice in the deed
- Board composition, THIBAU, Marc Pierre Antoine (director)
- Board composition, Skinmedicon (director)
- Permanent representative, BOURAKADI, Farah, mentioned twice in the deed
- Registered office clause, Flemish Region
- Director resignation, THIBAU, Marc Pierre Antoine (director (not named in the articles))
- Director resignation, Skinmedicon (director (not named in the articles))
- Director appointment, THIBAU, Marc Pierre Antoine (statutory director)
- Director appointment, Skinmedicon (statutory director)
- Board composition, Skinmedicon (statutory director)
- Board composition, THIBAU, Marc Pierre Antoine (statutory director)
- Power of attorney, Jeroen Uytterhaegen
- Director appointment, THIBAU, Marc Pierre Antoine (director (not named in the articles))
- Director appointment, Skinmedicon (director (not named in the articles))
- Registered office clause, 9000-Gent, Coupure Links 629/001
- The deed holds 19 more points.
2020
Annual accounts 2020 filed PDFabbreviated format · 26 days late
2019
Annual accounts 2019 filed PDFabbreviated format · 7 days late
2018
Annual accounts 2018 filed PDFmicro format · 1 day before the deadline
New managerSkinmedicon appointed, Bourakadi Farah resigned · Permanent representative: Bourakadi Farah · Director discharge: Bourakadi Farah (manager) · General meeting of 18-05-20185 points ▸
- General meeting, 18-05-2018
- Director resignation, Bourakadi Farah (manager)
- Director discharge, Bourakadi Farah (manager)
- Director appointment, Skinmedicon (manager)
- Permanent representative, Bourakadi Farah
2017
Annual accounts 2017 filed PDFmicro format · 24 days late
2016
Annual accounts 2016 filed PDFabbreviated format · 42 days before the deadline
2015
Annual accounts 2015 filed PDFabbreviated format · 2 days before the deadline
2014
Annual accounts 2014 filed PDFabbreviated format · 14 days before the deadline
Liquidity more than doubled current ratio 2.03 The current ratio rises from 0.94 to 2.03.
2013
Annual accounts 2013 filed PDFabbreviated format · 7 days late
Back to profit net €145 The net result is €145, after one loss-making year.
2012
Annual accounts 2012 filed PDFabbreviated format · 33 days late
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank